Regulatory Status and Progress of Stem Cell Preparations in China
Objective To provide a reference for the regulatory of the development of China's stem cell industry.Methods The current status of clinical research and application of stem cells,legislation and regulation of stem cell therapy at home and abroad,and the development status of the stem cell industry were summarized.The problems faced by the development of stem cell industry in China were analyzed to put forward targeted suggestions.Results Compared with the developed countries such as the United States of America(USA),China's clinical research and application of stem cells had problems such as incomplete ethical mechanisms construction,lack of legislation,and incomplete regulatory system.Conclusion It is recommended that China strengthen the construction of ethical mechanisms for clinical research on stem cells,legislate for stem cell products or stem cell therapies,establish a regulatory system for the stem cell industry that is in line with China's national conditions,and form a virtuous cycle of stem cell industry research and development,achievement transformation,and market application,in order to promote the development of stem cell industry in a standardized and safe manner in China.
万方数据
维普
